These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 673747)
1. [Status epilepticus and transient disorders of heart conduction induced by too fast intravenous infusion of naftidrofuryl]. Rey JL; Quiret JC; Gamain J; Errasti M Nouv Presse Med; 1978 May; 7(21):1864. PubMed ID: 673747 [No Abstract] [Full Text] [Related]
2. [Effect of intravenous naftidrofuryl on the microcirculation of patients in stages III and IV of arterial occlusive disease]. Abendroth D; Sunder-Plassmann L Vasa Suppl; 1988; 24():33-7. PubMed ID: 3212601 [No Abstract] [Full Text] [Related]
3. [Thrombocyte function in parenteral naftidrofuryl therapy]. Janka HU; Rinninger F; Mehnert H Ther Ggw; 1982 Jul; 121(7):422-33. PubMed ID: 7051401 [No Abstract] [Full Text] [Related]
4. [Local tolerance to perfusions of praxilene]. Courbier R Nouv Presse Med; 1977 Nov; 6(40):3755. PubMed ID: 604937 [No Abstract] [Full Text] [Related]
5. [Cardiovascular complications due to naftidrofuryl]. Ducloux G; Marchand X; Laurent JM; Lecoutour X; Puech F; Delecour M Ann Cardiol Angeiol (Paris); 1985 Mar; 34(3):167-9. PubMed ID: 3923893 [TBL] [Abstract][Full Text] [Related]
7. [Conservative treatment of arterial occlusive diseases with naftidrofuryl hydrogen oxalate (author's transl)]. Ratschow R MMW Munch Med Wochenschr; 1976 Sep; 118(36):1131-4. PubMed ID: 823407 [TBL] [Abstract][Full Text] [Related]
8. Severe thrombophlebitis with naftidrofuryl oxalate. Gann M Br Med J; 1977 Jun; 1(6076):1598. PubMed ID: 871682 [No Abstract] [Full Text] [Related]
9. [Massive poisoning by naftidrofuryl with severe disorders of rhythm and conduction]. Rey JL; Marek A; Tribouilloy C; Jarry G; Slama MA; Avinée P; Quiret JC; Bernasconi P Arch Mal Coeur Vaiss; 1989; 82(8):1467-71. PubMed ID: 2508601 [TBL] [Abstract][Full Text] [Related]
10. [Intravenous infusion of Naftidrofuryl in the treatment of arterial diseases of the limbs. Clinical and functional study]. Schmidt C; Royer RJ; Kissel P Therapie; 1974; 29(6):915-23. PubMed ID: 4618388 [No Abstract] [Full Text] [Related]
11. [Naftidrofuryl in stages III and IV of peripheral arterial occlusive disease]. Horsch S Vasa Suppl; 1988; 24():38-43. PubMed ID: 3212602 [No Abstract] [Full Text] [Related]
15. [Transcutaneous measures of oxygen partial pressure and capillaroscopic parameters as affected by naftidrofuryl in patients with obliterative arteriopathies, Fontaine stages II-IV]. Ranft J; Heidrich H; Lammersen T J Mal Vasc; 1987; 12(1):78-81. PubMed ID: 3559415 [TBL] [Abstract][Full Text] [Related]
17. [Functional results of oral dusodril therapy of obliterating arteriopathy of the lower extremities. Comparison of the angiogram, plethysmogram and Doppler ultrasound]. Weidinger P Med Welt; 1983 Apr; 34(17):531-4. PubMed ID: 6865725 [No Abstract] [Full Text] [Related]
18. [Allergic reaction in therapy with naftidrofuryl (Dusodril). A case report]. Matschke RG HNO; 1987 May; 35(5):219-21. PubMed ID: 3610682 [TBL] [Abstract][Full Text] [Related]
19. The effect of oxygen inhalation and intravenous naftidrofuryl on the transcutaneous partial oxygen pressure in ischaemic lower limbs. Mustapha NM; Jain SK; Dudley P; Redhead RG Prosthet Orthot Int; 1984 Dec; 8(3):135-8. PubMed ID: 6522254 [TBL] [Abstract][Full Text] [Related]
20. [Electrophysiological observations on seizure activity provoked by an intracarotid injection of Naftidrofuryl (author's transl)]. Samson-Dollfus D; Testart J Rev Electroencephalogr Neurophysiol Clin; 1977; 7(4):459-61. PubMed ID: 611593 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]